Quantitative real-time detection of parvovirus B19 DNA in plasma

Transfusion

Volumn 44, Issue 1, 2004, Pages 97-103

  Koppelman, Marco H G M ^a   Cuypers, H Theo M ^b   Emrich, Thomas ^b   Zaaijer, Hans L ^b  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; RHESUS D ANTIBODY; VIRUS DNA;

ARTICLE; ASSAY; BLOOD TRANSFUSION; CONTROLLED STUDY; DILUTION; DNA EXTRACTION; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PLASMA; POLYMERASE CHAIN REACTION; VIREMIA; VIRUS DETECTION;

BLOOD DONORS; COMPUTER SYSTEMS; DNA, VIRAL; HUMANS; MASS SCREENING; PARVOVIRUS B19, HUMAN; SENSITIVITY AND SPECIFICITY; VIREMIA;

EID: 0842303391     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0041-1132.2004.00610.x     Document Type: Article

References (26)

1. Prowse CV. Parvovirus B19 and blood products. Lancet 1994;343:1101.
2. Laurian Y, Dussaix E, Parquet A, et al. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates. Nouv Rev Fr Hematol 1994;36:449-53.
3. Azzi A, Ciappi S, Zakvrzewska K, et al. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992;39:228-30.
4. Hayakawa F, Imada K, Towatari M, Saito H. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin. Br J Haematol 2002;118:1187-9.
5. Mauser-Bunschoten EP, Zaaijer HL, van Drimmelen AA, et al. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients. Vox Sang 1998;74:225-7.
6. Koenigbauer UF, Eastlund T, Day JW. Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 2000;40:1203-6.
7. Saldanha J, Minor P. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol 1996;93:714-9.
8. Just B, Lefevre H. Detection of parvovirus B19 DNA in solvent-detergent plasma. Vox Sang 2002;83:167.
9. Schmidt I, Blumel J, Seitz H, et al. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang 2001;81:228-35.
10. McOmish F, Yap PL, Jordan A, et al. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993;31:323-8.
11. Yoto Y, Kudoh T, Haseyama K, et al. Incidence of human parvovirus B19V DNA detection in blood donors. Br J Haematol 1995;91:1017-8.
12. Anderson LJ, Tsou C, Parker RA, et al. Detection of antibodies and antigens of human parvovirus B19V by enzyme-linked immunosorbent assay. J Clin Microbiol 1986;24:522-6.
13. Anonymous. Human anti-D immunoglobulin. Pharm-europe 2002;14:81.
14. Saldanha J, Lelie N, Yu MW, Heath A. Establishment of the first World Health Organization International standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002;82:24-31.
15. Brown KE, Young NS, Alving BM, Barbosa LH. Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 2001;41:130-5.
16. Tabor E, Epstein JS. NAT screening of blood and plasma donations: evolution of technology and regulatory policy. Transfusion 2002;42:1230-7.
17. Weimer T, Streichert S, Watson C, Groner A. High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 2001;41:1500-4.
18. Aubin JT, Defer C, Vidaud M, et al. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang 2000;78:7-12.
19. Jongerius JM, Sjerps M, Cuijpers HT, et al. Validation of the NucliSens extractor combined with the Ampliscreen HIV Version 1.5. and HCV Version 2.0. test for application in NAT minipool screening. Transfusion 2002;42:792-7.
20. Daly P, Corcoran A, Mahon BP, Doyle S. High-sensitivity PCR detection of parvovirus B19 in plasma. J Clin Microbiol 2002;40:1958-62.
21. Aberham C, Pendl C, Gross P, et al. A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA. J Virol Meth 2001;92:183-91.
22. Manaresi E, Gallinella G, Zuffi E, et al. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol 2002;67:275-81.
23. Wittwer CT, Ririe KM, Andrew RV, et al. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997;22:176-81.
24. Boom R, Sol CJ, Salimans MM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
25. Engelfriet CP, Reesink HW. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology. Vox Sang 2002;82:87-111.
26. Laitinen H, Wessberg S, Palomaki P. Simultaneous blood donor screening of HCV-RNA and B19-DNA in Finland. Poster at 27th Congress of the International Society of Blood Transfusion (ISBT), Vancouver, Canada, August 24-29, 2002.